Concepedia

Nathalie Rioux

NR

Statistics

Publications

32

Citations

3.1K

H-Index

24

Active since

1997

Affiliations

Epizyme (United States)(Current)

Université Laval

Boehringer Ingelheim (Canada)

GlaxoSmithKline (United States)

Dana-Farber Cancer Institute

Nathalie Rioux is an author at Epizyme (United States) specializing in pharmacology, medicine, and cancer pharmacology.

ORCID

Publications per year

1997–2023

32

Publications

32

A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models

Elayne Chan-Penebre, Kristy G. Kuplast, Christina R. Majer et al. · Nature Chemical Biology · 2015 · 546 citations

, , +8

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 347 citations · Full text

, , +7

Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents

Nathalie Rioux · Carcinogenesis · 1998 · 205 citations · Full text

, , +16

Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.

Nathalie Rioux, André Castonguay · PubMed · 1998 · 203 citations

, , +11

Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666

Kenneth W. Duncan, Nathalie Rioux, P. Ann Boriack‐Sjodin et al. · ACS Medicinal Chemistry Letters · 2015 · 151 citations · Full text

, , +15

1–5 of 32